The acute dialysis quality initiative - Part V: Operational characteristics of CRRT

Advances in Renal Replacement Therapy

Volumn 9, Issue 4, 2002, Pages 268-272

  Palevsky, Paul M ^a   Bunchman, Timothy ^b   Tetta, Ciro ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Cyberonics Inc   (Italy)

Author keywords

Continuous renal replacement therapy; Hemodialysis; Hemofiltration

Indexed keywords

ARTERIOVENOUS FISTULA; CLINICAL PRACTICE; DIALYSIS; DIFFUSION; DRUG CLEARANCE; HEALTH CARE QUALITY; HEMODIALYSIS; HEMOFILTRATION; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 0036775798     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1053/jarr.2002.35567     Document Type: Article

References (24)

1. Ronco C, Bellomo R: Continuous renal replacement therapy: Evolution in technology and current nomenclature. Kidney Int 53:S160-164, 1998 (suppl)
2. Relton S, Greenberg A, Palevsky P: Dialysate and blood flow dependence of diffusive solute clearance during CVVHD. ASAIO J 38:M961-M696, 1992
3. Brunet S, Leblanc M, Geadah D, et al: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 34:486-492, 1999
4. Maxvold NJ, Smoyer WE, Custer JR, et al: Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 28:1161-1165, 2000
5. Kellum J, Johnson JP, Kramer D, et al: Diffusive vs. convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 26:1995-2000, 1998
6. Ronco C, Tetta C, Lupi A, et al: Removal of plateletactivating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 23:99-107, 1995
7. van Bommel EF, Hesse CJ, Jutte NH, et al: Cytokine kinetics (TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration: A laboratory and clinical study. Contrib Nephrol 116:62-65, 1995
8. Goldfarb S, Golper TA: Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 5:228-232, 1994
9. Bouman CS, van Olden RW, Stoutenbeek CP: Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 16:261-268, 1998
10. Tetta C, Mariano F, Buades J, et al: Relevance of platelet-activating factor in inflammation and sepsis: Mechanisms and kinetics of removal in extracorporeal treatments. Am J Kid Dis 30:S57-S65, 1997
11. Matzke GR, Frye RF, Joy MS, et al: Determinants of ceftazidime clearance by CVVH and CVVHD. Antimicrob Agents Chemo 44:1639-1644, 2000
12. Joy MS, Matzke GR, Frye RF, et al: Determinants of vancomycin clearance by CVVH and CVVHD. Am J Kidney Dis 31:1019-1027, 1998
13. Matzke GR, Frye RF, Joy MS, et al: Determinants of ceftriaxone clearance by CVVH and CVVHD. Pharmacotherapy 20:635-643, 2000
14. Golper TA, Marx MA: Drug dosing adjustments during continuous renal replacement therapies. Kidney Int 53:S165-S168, 1998 (suppl)
15. Stork M, Hartl WH, Zimmer E, et al: Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337:452-455, 1991
16. Macias WL, Mueller BA, Scarim SK, et al: Continuous venovenous hemofiltration: An alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 18:451-458, 1991
17. Tam PY-W, Huraib S, Mahan B, et al: Slow continuos hemodialysis for the management of complicated acute renal failure in an intensive care unit. Clin Nephrol 30:79-85, 1988
18. Bunchman TE, Maxvold NJ, Kershaw DB, et al: Continuous venovenous hemodiafiltration in infants and children. Am J Kidney Dis 25:17-21, 1995
19. Canaud B, Garred LJ, Christol J-P, et al: Pump assisted continuous venovenous hemofiltration for treating acute uremia. Kidney Int 33:S154-156, 1988
20. De Vriese AS, Colardyn FA, Philippe JJ, et al: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846-853, 1999
21. Mariano F, Guida G, Donati D, et al: Production of platelet-activating factor in patients with sepsis-associated acute renal failure. Nephrol Dial Transplant 14:1150-1157, 1999
22. Sieberth H-G, Kierdorf HP: Is cytokine removal by continuous hemofiltration feasible. Kidney Int 56:S79-S83, 1999
23. Jenkins R, Harrison H, Chen B, et al: Accuracy of intravenous infusion pumps in continuous renal replacement therapies. ASAIO J 38:808-810, 1992
24. Roberts M, Winney RJ: Errors in fluid balance with pump control of continuous hemodialysis. Int J Artific Organs 15:99-102, 1992